BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mroweh M, Roth G, Decaens T, Marche PN, Lerat H, Macek Jílková Z. Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:1794. [PMID: 33670268 DOI: 10.3390/ijms22041794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Razpotnik R, Vidmar R, Fonović M, Rozman D, Režen T. Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma. Cancers (Basel) 2022;14:4524. [PMID: 36139684 DOI: 10.3390/cancers14184524] [Reference Citation Analysis]
2 Kumar P, Singh AK, Verma P, Tiwari KN, Mishra SK. Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma. Med Oncol 2022;39:155. [PMID: 35852639 DOI: 10.1007/s12032-022-01759-z] [Reference Citation Analysis]
3 Shiau J, Chuang Y, Cheng Y, Tang J, Hou M, Yen C, Chang H. Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism. Antioxidants 2022;11:911. [DOI: 10.3390/antiox11050911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Jiang HY, Zheng HM, Xia C, Li X, Wang G, Zhao T, Cui XN, Wang RY, Liu Y. The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma. Onco Targets Ther 2022;15:291-8. [PMID: 35345394 DOI: 10.2147/OTT.S333233] [Reference Citation Analysis]
5 Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 2021. [PMID: 34907642 DOI: 10.1111/jcmm.17126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Xu L, Yang C, Wang J, Li Z, Huang R, Ma H, Ma J, Wang Q, Xiong X. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice. Biochem Biophys Res Commun 2021;578:142-9. [PMID: 34562654 DOI: 10.1016/j.bbrc.2021.09.036] [Reference Citation Analysis]
7 Gao JY, Chang CS, Lien JC, Chen TW, Hu JL, Weng JR. Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells. Biomedicines 2021;9:1527. [PMID: 34829756 DOI: 10.3390/biomedicines9111527] [Reference Citation Analysis]
8 Wang H, Chen X, Calvisi DF. Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics. Expert Opin Ther Targets 2021;25:645-58. [PMID: 34477018 DOI: 10.1080/14728222.2021.1976142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lu L, Zhang J, Fan W, Li Y, Wang J, Li TWH, Torres LB, Mato JM, Liu T, Seki E, Matsuda M, Tomasi ML, Bhowmick NA, Yang H, Lu SC. Deregulated 14-3-3ζ and methionine adenosyltransferase α1 interplay promotes liver cancer tumorigenesis in mice and humans. Oncogene 2021. [PMID: 34349244 DOI: 10.1038/s41388-021-01980-6] [Reference Citation Analysis]